Biomedical subjects

Shahid Rasul

Publications and source records attributed to Shahid Rasul.

3 recordsLinked to original sources

PubMed2005

Toxicity profile and objective response of paclitaxel in metastatic breast cancer.

OBJECTIVE: To evaluate the efficacy and toxicity of 1-hour weekly Paclitaxel in metastatic breast cancer along with evaluation of overall survival. DESIGN: A phase II interventional trial. PLACE AND DURATION OF STUDY: Oncology Department, Combined Military Hospital, Rawalpindi, between August 2001 to July 2003. PATIENTS AND METHODS: Thirty-six patients were enrolled in the study. All patients with histologically confirmed and bi-dimensionally measurable metastatic breast cancer who had received previously either chemotherapy or hormone therapy were included in the study. Paclitaxel was administered in 1-hour weekly infusion in a dose of 100 mg/m2 for 12 doses. RESULTS: All patients had received previous chemotherapy with either CAF or CMF. Twenty-five patients had also received hormone therapy, 61% had two or more metastatic sites involved, and lung was the common site of involvement. Complete response was observed in 4 (11.1%) patients, partial response in 14 (38.8%) patients, with an overall response rate of 50.0%. Clinical benefit was 94.4% and median overall survival was 11 months. Treatment was well-tolerated with no grade 3 or 4 toxicity. Common side effects were arthralgias, myalgias and neutropenia. CONCLUSION: Treatment with 1-hour weekly infusion of Paclitaxel is a well-tolerated chemotherapy with a substantial degree of efficacy in patients with metastatic breast cancer.

Adult↗

PubMed2005

Tuberculous mastitis.

OBJECTIVE: To find out the different clinical presentations of breast tuberculosis and its treatment outcome. DESIGN: An observational study. PLACE AND DURATION OF STUDY: Surgical ward 3 of Jinnah Postgraduate Medical Centre, Karachi from June 2001 to November 2003. SUBJECTS AND METHODS: Fifty consecutive female patients above 13 years presenting with breast lump, multiple sinuses, axillary lymphadenopathy, and cold abscess were included in the study. Medical records of the patients presented were reviewed and analyzed. Data was collected regarding the patient's name, age and marital and lactational status. Clinical Examinations and investigations were carried out by triple assessment i.e. clinical, radiological and histological / cytological evaluation. RESULTS: The commonest presentation was a solitary breast lump in 30 (60%) patients, breast lump with axillary lymphadenopathy in 13 (26%). Four (8%) patients presented with generalized breast swelling (edema) with ipsilateral axillary lymphadenopathy. Two (4%) presented with breast abscess and axillary lymphadenopathy and one (2%) with axillary sinus and breast lump. Upper outer quadrant was most frequently involved in 29 (58%) of patients. Thirty-two (64%) cases were secondary to tuberculosis in other sites, mostly (40%) from tuberculous axillary lymphadenitis. Forty-eight (96%) patients responded well to one year antituberculous treatment with complete disappearance of the lumps except 2 patients who had shrinkage of lump size only, underwent excision of lump. CONCLUSION: Solitary lump and enlarged lymph nodes are the commonest presentation of mammary tuberculosis. Early diagnosis and treatment is necessary to prevent disfigurement of breast. Antituberculous therapy is the treatment of choice. Surgery should be reserved for unresponsive lumps.

Adolescent↗

PubMed2005

Dermatofibrosarcoma protuberans.

Dermatofibrosarcoma protuberans is a rare, locally aggressive, rarely metastatic skin tumor which tends to recur. A 45-year-old female presented with dermatofibrosarcoma protuberans on her breast as a recurrent nodule after excision. Lump was re-excised with wide margins and irradiated. Follow-up was done monthly for two years, with no recurrence.

Breast↗